$47.4 Million is the total value of HealthInvest Partners AB's 16 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 33.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ANIK | Sell | ANIKA THERAPEUTICS INC | $6,178,000 | -7.4% | 114,600 | -0.3% | 13.04% | +67.4% |
| CRL | Sell | CHARLES RIV LABS INTL INC | $2,924,000 | -55.5% | 26,712 | -56.1% | 6.17% | -19.5% |
| LH | Sell | LABORATORY CORP AMER HLDGS | $2,839,000 | -55.5% | 17,800 | -57.9% | 5.99% | -19.7% |
| DGX | New | QUEST DIAGNOSTICS INC | $2,807,000 | – | 28,500 | +100.0% | 5.92% | – |
| CAH | New | CARDINAL HEALTH INC | $2,794,000 | – | 45,600 | +100.0% | 5.90% | – |
| MCK | Sell | MCKESSON CORP | $2,776,000 | -73.7% | 17,800 | -74.1% | 5.86% | -52.4% |
| ANTM | Sell | ANTHEM INC | $2,768,000 | -73.6% | 12,300 | -77.7% | 5.84% | -52.3% |
| LGND | Sell | LIGAND PHARMACEUTICALS INC | $2,766,000 | -57.6% | 20,200 | -57.8% | 5.84% | -23.3% |
| MDT | Sell | MEDTRONIC PLC | $2,762,000 | -56.7% | 34,200 | -58.3% | 5.83% | -21.8% |
| CI | Sell | CIGNA CORPORATION | $2,721,000 | -58.6% | 13,400 | -61.9% | 5.74% | -25.3% |
| PFE | Sell | PFIZER INC | $2,720,000 | -58.0% | 75,100 | -58.6% | 5.74% | -24.0% |
| WAT | Sell | WATERS CORP | $2,705,000 | -58.0% | 14,000 | -61.0% | 5.71% | -24.1% |
| LLY | New | LILLY ELI & CO | $2,703,000 | – | 32,000 | +100.0% | 5.70% | – |
| BIIB | Sell | BIOGEN INC | $2,676,000 | -58.1% | 8,400 | -58.8% | 5.65% | -24.3% |
| BMY | New | BRISTOL MYERS SQUIBB CO | $2,660,000 | – | 43,400 | +100.0% | 5.61% | – |
| GILD | Sell | GILEAD SCIENCES INC | $2,586,000 | -58.3% | 36,100 | -52.9% | 5.46% | -24.7% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-02-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CHARLES RIV LABS INTL INC | 17 | Q4 2017 | 12.8% |
| GILEAD SCIENCES INC | 16 | Q4 2022 | 14.5% |
| CARDINAL HEALTH INC | 15 | Q4 2022 | 14.8% |
| IMMUCELL CORP | 15 | Q2 2017 | 1.7% |
| MCKESSON CORP | 14 | Q3 2022 | 14.6% |
| ANTHEM INC | 12 | Q4 2017 | 14.3% |
| TRIPLE-S MGMT CORP | 12 | Q4 2016 | 8.7% |
| LIFEPOINT HOSPITALS INC | 11 | Q2 2016 | 13.3% |
| SUPERNUS PHARMACEUTICALS INC | 10 | Q3 2021 | 15.5% |
| ANIKA THERAPEUTICS INC | 10 | Q4 2017 | 13.0% |
View HealthInvest Partners AB's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| NOVAMED INC | March 03, 2011 | 405,875 | 5.1% |
| THERAGENICS CORP | February 11, 2009 | 3,322,846 | 9.9% |
| BIO IMAGING TECHNOLOGIES INC | January 09, 2009 | 766,425 | 5.3% |
| ALLION HEALTHCARE INC | July 07, 2008 | 887,255 | 4.6% |
| SONIC INNOVATIONS INC | June 26, 2008 | 1,328,201 | 4.9% |
| CANDELA CORP /DE/ | June 06, 2008 | 697,164 | 3.1% |
| INTEGRAMED AMERICA INC | June 02, 2008 | 2,200 | 0.0% |
| AFP IMAGING CORP | February 04, 2008 | 27,520 | 0.2% |
| OPHTHALMIC IMAGING SYSTEMS | December 28, 2007 | 834,440 | 4.9% |
| ANGEION CORP/MN | October 16, 2007 | 196,024 | 4.8% |
View HealthInvest Partners AB's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-25 |
| 13F-HR | 2024-01-30 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-10-21 |
| 13F-HR | 2022-07-08 |
| 13F-HR | 2022-05-05 |
| 13F-HR | 2022-01-18 |
| 13F-HR | 2021-11-08 |
| 13F-HR | 2021-08-10 |
| 13F-HR | 2021-04-30 |
View HealthInvest Partners AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.